Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
BronchiectasisLung DiseaseRespiratory Diseases
Interventions
DRUG

AZD5069

Oral dose bid

DRUG

Placebo

Oral dose bid

Trial Locations (15)

Unknown

Research Site, Ostrava

Research Site, Prague

Research Site, Krakow

Research Site, Lodz

Research Site, Warsaw

Research Site, Hull

Research Site, Leicester

Research Site, Birmingham

Research Site, Belfast

Research Site, Bristol

Research Site, Cambridge

Research Site, London

Research Site, Newcastle upon Tyne

Research Site, Salford

Research Site, Wolverhampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY